{
  "meta": {
    "title": "00248_Late_Night_Pyqs_Neetpg-2",
    "url": "https://brainandscalpel.vercel.app/00248-late-night-pyqs-neetpg-2-d10e8c18.html",
    "scrapedAt": "2025-11-29T17:28:01.646Z"
  },
  "questions": [
    {
      "id": 6518,
      "choices": [
        {
          "id": 26041,
          "text": "<p><span style=\"font-size:12.0pt;\">Aliskiren</span></p>"
        },
        {
          "id": 26042,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorthalidone</span></p>"
        },
        {
          "id": 26043,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 26044,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with renal insufficiency had very low urine output, pedal edema, headache, and a blood pressure of 160/90. Which antihypertensive medication can be used? (NEET PG 2021)</span></p>",
      "unique_key": "Q8607196",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Amlodipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with renal insufficiency and low urine output, the preferred antihypertensive medication would be one that is safe in renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amlodipine is a good choice because it is a calcium channel blocker that does not affect renal function. Although it can cause pedal edema in some patients but the pedal edema which is given in the question seems to be due to renal insufficiency itself. The adverse effect of pedal edema does not make it contra-indicated for hypertension.&nbsp;&nbsp;It also has a long duration of action and is well-tolerated in patients with renal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aliskiren: </strong>Aliskiren is a direct renin inhibitor that can lead to severe hyperkalemia, particularly in patients with renal insufficiency. Hyperkalemia can exacerbate renal dysfunction and pose serious health risks, making aliskiren an unsuitable choice for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chlorthalidone: </strong>Chlorthalidone is a thiazide-like diuretic. Thiazide diuretics are typically ineffective in patients with significantly impaired renal function (e.g., low GFR) and can cause electrolyte imbalances, including hypokalemia and hyponatremia. Therefore, chlorthalidone is not recommended for patients with renal insufficiency and low urine output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prazosin: </strong>Prazosin is an alpha-blocker used to lower blood pressure. However, it is not typically a first-line drug for hypertension due to its side effects, such as postural hypotension. Additionally, prazosin can cause fluid retention, which may worsen renal function in patients with renal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amlodipine is the preferred antihypertensive medication for patients with renal insufficiency, as it effectively lowers blood pressure without negatively impacting renal function.</span></p>",
      "correct_choice_id": 26043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80093,
      "choices": [
        {
          "id": 319088,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 319089,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 319090,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 319091,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In polyarticular onset juvenile idiopathic arthritis (JIA), the condition involves more than how many joints? (NEET PG 2015)</span></p>",
      "unique_key": "Q4801945",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021126,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polyarticular juvenile idiopathic arthritis (JIA) is defined by the involvement of 5 or more joints during the first 6 months of disease. This subtype of JIA affects approximately 25-40% of children with juvenile arthritis and can be further classified as rheumatoid factor positive or negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The classification of JIA is based on the number of joints involved in the initial 6 months:</span></p><ul><li><span style=\"font-size:12.0pt;\">Oligoarticular JIA: affects 4 or fewer joints</span></li><li><span style=\"font-size:12.0pt;\">Polyarticular JIA: affects 5 or more joints</span></li><li><span style=\"font-size:12.0pt;\">Systemic JIA: characterized by arthritis with systemic features including fever and rash</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 3 - Incorrect</strong>. Involvement of 3 joints would be classified as oligoarticular JIA, which is defined as arthritis affecting 4 or fewer joints.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 4 - Incorrect</strong>. Involvement of 4 joints would still be classified as oligoarticular JIA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 6 - Incorrect</strong>. While 6 joints would qualify as polyarticular JIA, the minimum threshold is 5 joints, not 6.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polyarticular JIA is defined by involvement of ≥5 joints during the first 6 months, while oligoarticular JIA involves ≤4 joints. This distinction is critical for proper classification, treatment approach, and prognostication.</span></p>",
      "correct_choice_id": 319090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6534,
      "choices": [
        {
          "id": 26105,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 26106,
          "text": "<p><span style=\"font-size:12.0pt;\">Donepezil</span></p>"
        },
        {
          "id": 26107,
          "text": "<p><span style=\"font-size:12.0pt;\">Selegiline</span></p>"
        },
        {
          "id": 26108,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly man presents with rigidity and tremors. On examination, he has blank facial expressions. Which of the following drugs can be used to manage this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7492175",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Selegiline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of rigidity, tremors, and blank facial expressions are suggestive of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Selegiline is a monoamine oxidase B (MAO-B) inhibitor that is used in the management of Parkinson's disease. It works by inhibiting the breakdown of dopamine, thereby increasing its availability in the brain and helping to alleviate symptoms like rigidity and tremors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clozapine</strong>: Clozapine is an atypical antipsychotic primarily used in the treatment of schizophrenia. While it can be used in Parkinson's disease patients who experience psychosis, it is not a first-line treatment for the primary motor symptoms of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Donepezil</strong>: Donepezil is an acetylcholinesterase inhibitor used in the treatment of Alzheimer’s disease. It enhances cholinergic function by increasing the concentration of acetylcholine in the brain. It is not typically used for treating Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haloperidol</strong>: Haloperidol is a typical antipsychotic and can actually worsen Parkinson's disease symptoms. It blocks dopamine receptors, which could exacerbate the dopamine deficiency characteristic of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Selegiline is a monoamine oxidase B (MAO-B) inhibitor that increases dopamine availability in the brain and is used to manage the motor symptoms of Parkinson's disease, such as rigidity and tremors.</span></p>",
      "correct_choice_id": 26107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20919,
      "choices": [
        {
          "id": 83640,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibit extrinsic pathway</span></p>"
        },
        {
          "id": 83641,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits platelet aggregation</span></p>"
        },
        {
          "id": 83642,
          "text": "<p><span style=\"font-size:12.0pt;\">Enhance fibrin degradation</span></p>"
        },
        {
          "id": 83643,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibit clot formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The mechanism of action of tissue plasminogen activator is: (NEET PG 2023)</span></p>",
      "unique_key": "Q2275137",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021131,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Enhance fibrin degradation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tissue plasminogen activators (tPA) converts plasminogen to plasmin that breaks&nbsp;the thrombus, which results in fibrinolysis of formed thrombus (thrombolysis).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drugs in this class include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">S – Streptokinase</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">U – Urokinase</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">R – Reteplase</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A – Alteplase</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">T – Tenecteplase</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indication → Pulmonary embolism with hemodynamic instability</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute ischemic stroke</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute MI</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Overdose of thrombolytics</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Leads to bleeding</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Antidotes: Epsilon Amino Caproic Acid [EACA]</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tranexamic Acid</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Inhibit extrinsic pathway:&nbsp;</strong>This is not the mechanism of tPA. The extrinsic pathway involves the activation of clotting factors by tissue factor and is more related to clot formation rather than breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Inhibits platelet aggregation:&nbsp;</strong>This is not the mechanism of tPA. Platelet aggregation is inhibited by drugs like aspirin and clopidogrel, not by tPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibit clot formation:&nbsp;</strong>This is not the mechanism of tPA. Inhibition of clot formation is achieved by anticoagulants like heparin and warfarin, whereas tPA is involved in clot breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tissue plasminogen activator (tPA) enhances fibrin degradation by converting plasminogen to plasmin, leading to the dissolution of blood clots.</span></p>",
      "correct_choice_id": 83642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76186,
      "choices": [
        {
          "id": 303617,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">A-Culex, B-Aedes</span></p>"
        },
        {
          "id": 303618,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">A-Anopheles, B-Culex</span></p>"
        },
        {
          "id": 303619,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">A-Culex, B-Anopheles</span></p>"
        },
        {
          "id": 303620,
          "text": "<p><span style=\"font-size:16px;\">A-Aedes, B-Culex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Identify A and B in the image given: (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_A0j9rW3.png\" width=\"415\" height=\"293\"></span></p>",
      "unique_key": "Q2230632",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021134,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) A-Anopheles, B-Culex</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The image shows mosquito larvae in water. <strong>Anopheles larvae (A</strong>) rest parallel to the water surface because they have <strong>no siphon tub</strong>e and can take oxygen directly through the water surface and skin. In contrast, <strong>Culex larvae (B)</strong> have a siphon tube (like a nose) so they attach to water surface at an angle using this siphon tube. The characteristic positioning of these larvae helps in their identification - <strong>Anopheles parallel to surface, while Culex at an angle.</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>&nbsp;Option A. A-Culex, B-Aedes: Incorrect because</strong> Culex larvae rest at an angle to water surface, not parallel like shown in A.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. A-Culex, B-Anopheles: Incorrect because</strong> the positioning is reversed. Anopheles rests parallel (A), not B.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. A-Aedes, B-Culex: Incorrect because</strong> Aedes larvae, like Culex, have a siphon tube and rest at an angle, not parallel like shown in A.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5RSINgF.png\" width=\"883\" height=\"676\"></span></p>",
      "correct_choice_id": 303618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80096,
      "choices": [
        {
          "id": 319100,
          "text": "<p><span style=\"font-size:12.0pt;\">Deafness</span></p>"
        },
        {
          "id": 319101,
          "text": "<p><span style=\"font-size:12.0pt;\">Cataract</span></p>"
        },
        {
          "id": 319102,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart defect</span></p>"
        },
        {
          "id": 319103,
          "text": "<p><span style=\"font-size:12.0pt;\">Microcephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most prevalent defect observed in Congenital Rubella Syndrome? (NEET PG 2015)</span></p>",
      "unique_key": "Q7278939",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Deafness</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Congenital Rubella Syndrome (CRS) is characterized by a triad of defects including sensorineural hearing loss, ocular abnormalities (such as cataracts), and congenital heart defects. Among these manifestations, sensorineural deafness is the most common and prevalent defect, affecting approximately 80% of infants with CRS. The hearing impairment is typically bilateral and can range from mild to profound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The classic triad of CRS includes:</span></p><ul><li><span style=\"font-size:12.0pt;\">Sensorineural deafness (most common)</span></li><li><span style=\"font-size:12.0pt;\">Eye abnormalities (cataracts, microphthalmia, glaucoma)</span></li><li><span style=\"font-size:12.0pt;\">Cardiac defects (most commonly PDA)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of defects is highest when maternal infection occurs during the first trimester, particularly before 11 weeks of gestation, when the risk of defects is approximately 90%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cataract - Incorrect</strong>. While cataracts are a characteristic feature of CRS, they are less common than hearing impairment, occurring in approximately 30-40% of affected infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Heart defect - Incorrect</strong>. Cardiac defects (particularly PDA, followed by peripheral pulmonary artery stenosis) occur in about 50-60% of CRS cases, making them less prevalent than deafness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Microcephaly - Incorrect</strong>. Microcephaly is observed in CRS but at a lower frequency compared to hearing impairment. It is part of the neurological manifestations that may include developmental delay and intellectual disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sensorineural deafness is the most common manifestation of Congenital Rubella Syndrome, which is why hearing assessment is critical for all infants with suspected in-utero rubella exposure, even in the absence of other clinical features.</span></p>",
      "correct_choice_id": 319100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76191,
      "choices": [
        {
          "id": 303637,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Case control study</span></p>"
        },
        {
          "id": 303638,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Prospective study</span></p>"
        },
        {
          "id": 303639,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Cross sectional study</span></p>"
        },
        {
          "id": 303640,
          "text": "<p><span style=\"font-size:16px;\">Ecological study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a study based in Delhi from 2012-2022, doctors followed up 100 people who did exercise on a daily basis for a year. Later, they checked who all had developed coronary heart disease among them. This is a type of: (FMGE JAN 2025)</span></p>",
      "unique_key": "Q9292484",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021358,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) Prospective study</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">This is a prospective or cohort study because:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The exposure (<strong>exercise</strong>) was identified first</span></li><li><span style=\"font-size:16px;\">The subjects were followed up over time (<strong>10 years from 2012 to 2022</strong>)</span></li><li><span style=\"font-size:16px;\">The outcome <strong>(coronary heart disease)</strong> was measured later</span></li><li><span style=\"font-size:16px;\">The direction of the study is forward in time <strong>(from exposure to outcome)</strong></span></li><li><span style=\"font-size:16px;\">The study follows a group of similar individuals (cohort) over time</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option A. Case control study:&nbsp;</strong>Incorrect because case control studies are retrospective, starting with the outcome (disease) and looking back at exposures. Here, the study started with exposure and looked forward.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Cross sectional study:&nbsp;</strong>Incorrect because cross sectional studies measure exposure and outcome at the same point in time. This study involved follow-up over 10 years.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Ecological study:&nbsp;</strong>Incorrect because ecological studies analyze population-level data rather than individual data. This study followed individual subjects.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">A study that starts with exposure, follows subjects over time, and measures outcomes later is a prospective/cohort study.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dqWvmmv.png\" width=\"975\" height=\"298\"></span></p>",
      "correct_choice_id": 303638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55535,
      "choices": [
        {
          "id": 221593,
          "text": "<p><span style=\"font-size:12.0pt;\">Left bronchus</span></p>"
        },
        {
          "id": 221594,
          "text": "<p><span style=\"font-size:12.0pt;\">Main bronchus</span></p>"
        },
        {
          "id": 221595,
          "text": "<p><span style=\"font-size:12.0pt;\">Right bronchus</span></p>"
        },
        {
          "id": 221596,
          "text": "<p><span style=\"font-size:12.0pt;\">Arch of aorta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During endoscopy, the endoscope has reached 25 cm from the incisor teeth. The endoscope has reached till: (FMGE JULY 2024)&nbsp;&nbsp;&nbsp;&nbsp;</span></p>",
      "unique_key": "Q2109240",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021133,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Arch of aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During an endoscopy, the distance from the incisor teeth to various anatomical landmarks in the esophagus is measured in centimeters. The esophagus is a muscular tube that passes through the thorax to the stomach. The significant landmarks that the endoscope passes as it moves down include the pharyngo-esophageal junction, the arch of the aorta, the left bronchus, and finally the diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">At 25 cm from the incisor teeth, the endoscope reaches the level of the arch of aorta. This is anatomically located around the T4 vertebra level. The arch of aorta causes a slight indentation in the esophagus, which is why it's a key point of reference during endoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-100523.png\" alt=\"\" width=\"400\" height=\"546\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cricopharyngeal junction - C6 – 6” (15 cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Arch of aorta - T4 – 9” (22.5 cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Left bronchus - T6 – 11” (27.5 cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diaphragm - T10 – 15” (37.5 cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Left bronchus</strong>: The left bronchus is located slightly below the arch of aorta, typically around 27.5 cm from the incisor teeth, corresponding to the T6 vertebra level. Therefore, at 25 cm, the endoscope has not yet reached the left bronchus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Main bronchus</strong>: The term \"main bronchus\" is often a general term that could refer to either the left or right bronchus. However, anatomically, both bronchi are located below the level of the arch of aorta, making this option incorrect for the 25 cm mark.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Right bronchus</strong>: The right bronchus, similar to the left, is located at a point beyond 25 cm from the incisor teeth, typically after the endoscope has passed the level of the arch of aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">At 25 cm from the incisor teeth during an endoscopy, the endoscope has reached the level of the arch of aorta. This is a crucial anatomical landmark and is typically located at the T4 vertebra level</span></p>",
      "correct_choice_id": 221596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80060,
      "choices": [
        {
          "id": 318956,
          "text": "<p><span style=\"font-size:12.0pt;\">Fissula Ante-fenestram</span></p>"
        },
        {
          "id": 318957,
          "text": "<p><span style=\"font-size:12.0pt;\">Fossula Post-fenestram</span></p>"
        },
        {
          "id": 318958,
          "text": "<p><span style=\"font-size:12.0pt;\">Footplate of Stapes&nbsp;</span></p>"
        },
        {
          "id": 318959,
          "text": "<p><span style=\"font-size:12.0pt;\">Oval Window</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Otosclerosis most commonly begins at which of the following locations?&nbsp;(NEET PG 2017)</span></p>",
      "unique_key": "Q2691291",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fissula Ante-fenestram</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Otosclerosis most commonly begins at the fissula ante fenestram. This is a small depression located in front of the oval window in the otic capsule. This is the initial site where the abnormal bone remodeling process begins, which eventually extends to involve the stapes footplate causing its fixation and conductive hearing loss. The fissula ante fenestrum is considered the classic starting point for otosclerotic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fossula Post-fenestram</strong>: While otosclerotic foci can develop in various locations within the otic capsule, the fossula post-fenestram (behind the oval window) is not the most common initial site. Otosclerosis predominantly begins at the area anterior to the oval window (fissula ante fenestram).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Footplate of Stapes</strong>: Although the stapes footplate is eventually involved in otosclerosis, leading to the characteristic stapes fixation and conductive hearing loss, it is not typically the primary site where the disease process begins. The disease usually starts in the fissula ante fenestram and then extends to involve the footplate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oval Window</strong>: The oval window itself is not the initial site of otosclerotic change. The oval window is the opening between the middle and inner ear into which the stapes footplate fits. Otosclerosis begins in the bone adjacent to this structure (in the fissula ante fenestram) and then extends to involve the stapes footplate and oval window area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Otosclerosis characteristically begins in the fissula ante fenestram (anterior to the oval window) before extending to involve the stapes footplate, causing the fixation that leads to conductive hearing loss.</span></p>",
      "correct_choice_id": 318956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57296,
      "choices": [
        {
          "id": 228561,
          "text": "<p><span style=\"font-size:12.0pt;\">BAL (British Anti-Lewisite)</span></p>"
        },
        {
          "id": 228562,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        },
        {
          "id": 228563,
          "text": "<p><span style=\"font-size:12.0pt;\">DTPA</span></p>"
        },
        {
          "id": 228564,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following chelating agents is contraindicated in iron poisoning? (NEET PG 2024)</span></p>",
      "unique_key": "Q3151992",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021132,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) BAL (British Anti-Lewisite)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite), also known as dimercaprol, is contraindicated in cases of iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL should not be used in this case because it can form toxic complexes with iron, exacerbating the condition rather than alleviating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. EDTA:</strong> EDTA is a chelating agent used primarily for lead and other heavy metals, but it is not contraindicated in iron poisoning. However, it is not the preferred chelating agent for iron poisoning either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. DTPA:</strong> DTPA (Diethylenetriamine pentaacetic acid) is another chelating agent used for certain radioactive heavy metals and is not specifically contraindicated in iron poisoning, although it is not used for iron either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Desferrioxamine:</strong> Desferrioxamine is the chelating agent of choice in iron poisoning. It binds to free iron and forms a complex that is excreted in the urine, making it effective in reducing iron levels in cases of acute iron toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite) is contraindicated in Cadmium and Iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Desferrioxamine is the appropriate chelating agent to use in cases of iron poisoning.</span></p>",
      "correct_choice_id": 228561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76190,
      "choices": [
        {
          "id": 303633,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Zinc deficiency</span></p>"
        },
        {
          "id": 303634,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Vitamin A deficiency</span></p>"
        },
        {
          "id": 303635,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Vitamin C deficiency</span></p>"
        },
        {
          "id": 303636,
          "text": "<p><span style=\"font-size:16px;\">Copper deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Identify the deficiency of the nutrient as given in the image of a child: (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wVxurfa.png\" width=\"379\" height=\"290\"></span></p>",
      "unique_key": "Q8584495",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021350,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. A) Zinc deficiency</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The image shows <strong>acrodermatitis enteropathica,</strong> which is a characteristic manifestation of <strong>zinc deficiency</strong>. This condition presents with skin manifestations along with other symptoms like <strong>diarrhea, brittle nails,</strong> and in severe cases can lead to sterility in older patients. The skin lesions typically appear as <strong>eczematous and psoriasiform plaques&nbsp;</strong>in acral and periorificial locations.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option B. Vitamin A deficiency:&nbsp;</strong>Incorrect because Vitamin A deficiency primarily manifests as xerophthalmia with ocular changes like Bitot's spots, night blindness, and corneal changes, not the skin manifestations shown in the image.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Vitamin C deficiency:&nbsp;</strong>Incorrect because Vitamin C deficiency (scurvy) presents with bleeding gums, poor wound healing, and petechial hemorrhages, not the characteristic skin lesions shown.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Copper deficiency:&nbsp;</strong>Incorrect because copper deficiency (pseudoscurvy) has different manifestations including anemia and neurological symptoms, not the skin manifestations shown in the image.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Characteristic skin manifestations of <strong>acrodermatitis enteropathica</strong> as a sign of zinc deficiency, which includes eczematous lesions accompanied by systemic symptoms like diarrhea and brittle nails.</span></p>",
      "correct_choice_id": 303633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80108,
      "choices": [
        {
          "id": 319148,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxygen supplementation is necessary.</span></p>"
        },
        {
          "id": 319149,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyanotic heart disease is suspected.</span></p>"
        },
        {
          "id": 319150,
          "text": "<p><span style=\"font-size:12.0pt;\">This infant is achieving desired target oxygen saturation.</span></p>"
        },
        {
          "id": 319151,
          "text": "<p><span style=\"font-size:12.0pt;\">Supplemental oxygen should be given at 100% concentration.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A term infant has a preductal oxygen saturation of 85%, 5 minutes after birth. Which of the following is true? (NEET PG 2016)</span></p>",
      "unique_key": "Q4420720",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021127,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. This infant is achieving desired target oxygen saturation.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal oxygen saturation in newborns follows a predictable pattern after birth as the transition from fetal to neonatal circulation occurs. According to neonatal resuscitation guidelines, the preductal oxygen saturation (measured at right hand) at 5 minutes of life should be between 80-85%. The target ranges progress from 60-65% at 1 minute, 65-70% at 2 minutes, 70-75% at 3 minutes, 75-80% at 4 minutes, 80-85% at 5 minutes, and 85-95% at 10 minutes. Therefore, a preductal oxygen saturation of 85% at 5 minutes is within the normal range for a newborn and does not require intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oxygen supplementation is necessary</strong> - Incorrect. Supplemental oxygen is not needed when SpO2 is within normal range for age in minutes. Unnecessary oxygen can cause hyperoxemia and oxidative stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cyanotic heart disease is suspected</strong> - Incorrect. This oxygen level is normal for a 5-minute-old infant, not suggestive of congenital heart disease. PaO2 &lt;100mmHg despite 100% oxygen for 10-15 minutes - hyperoxia test fail suggesting cyanotic heart disease is likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Supplemental oxygen should be given at 100% concentration</strong> - Incorrect. Not only is supplemental oxygen unnecessary at this saturation, but 100% oxygen is no longer recommended in neonatal resuscitation except in specific circumstances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal oxygen saturation in newborns rises gradually after birth, with 80-85% being the normal target range at 5 minutes of life. Understanding these normal transitional physiology values prevents unnecessary oxygen administration.</span></p>",
      "correct_choice_id": 319150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57297,
      "choices": [
        {
          "id": 228565,
          "text": "<p><span style=\"font-size:12.0pt;\">Clearance</span></p>"
        },
        {
          "id": 228566,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume of distribution</span></p>"
        },
        {
          "id": 228567,
          "text": "<p><span style=\"font-size:12.0pt;\">Half-life</span></p>"
        },
        {
          "id": 228568,
          "text": "<p><span style=\"font-size:12.0pt;\">Bioavailability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine is used in a loading dose for the treatment of arrhythmias. The loading dose of this drug depends upon which of the following factors? (NEET PG 2024)</span></p>",
      "unique_key": "Q5630397",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021140,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Volume of distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of a drug is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-185420.jpg\" alt=\"\" width=\"700\" height=\"58\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of Lignocaine, which is administered intravenously (IV) for the treatment of arrhythmias, the bioavailability is 100% because the drug is delivered directly into the bloodstream. Therefore, bioavailability does not factor into the calculation when the drug is given IV. The critical factor influencing the loading dose in this scenario is the <strong>volume of distribution (Vd)</strong>, which represents the extent to which the drug distributes into body tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clearance</strong>: Clearance relates to the maintenance dose rather than the loading dose. It reflects the body's efficiency in eliminating the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Half-life</strong>: Half-life is important for determining dosing intervals and steady-state concentration but does not directly determine the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bioavailability</strong>: While bioavailability is included in the loading dose calculation, it is only a determining factor when the drug is not administered intravenously. In this case, where Lignocaine is given IV, bioavailability is 100% and thus does not influence the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>volume of distribution</strong> is the key factor that determines the loading dose of a drug, especially in intravenous administration where bioavailability is 100%</span></p>",
      "correct_choice_id": 228566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55536,
      "choices": [
        {
          "id": 221597,
          "text": "<p><span style=\"font-size:12.0pt;\">Lienorenal ligament</span></p>"
        },
        {
          "id": 221598,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrosplenic ligament</span></p>"
        },
        {
          "id": 221599,
          "text": "<p><span style=\"font-size:12.0pt;\">Lesser omentum</span></p>"
        },
        {
          "id": 221600,
          "text": "<p><span style=\"font-size:12.0pt;\">Greater omentum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked structure: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:2241/1547;width:54.12%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/00000_cleanup.png\" width=\"2241\" height=\"1547\"></span></p>",
      "unique_key": "Q5296977",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021141,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Lienorenal ligament</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked in the image is identified as the lienorenal ligament. The lienorenal ligament is a peritoneal ligament that connects the spleen to the left kidney. It is crucial because it contains important structures such as the splenic artery and vein.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided image, you can see the vertebra centrally located, with the kidneys visible on each side. The spleen, which lies adjacent to the stomach, is connected to the kidney by the lienorenal ligament. The splenic artery, a branch of the celiac trunk, passes through this ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During surgical procedures, especially when ligating the splenic artery, knowledge of this ligament's anatomy is essential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gastrosplenic ligament</strong>: This ligament connects the greater curvature of the stomach to the spleen. It contains the short gastric arteries and the left gastroepiploic artery. However, in the provided image, the marked structure does not represent this ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lesser omentum</strong>: The lesser omentum is a double layer of peritoneum extending from the liver to the lesser curvature of the stomach and the first part of the duodenum. It contains the portal triad (portal vein, hepatic artery, and bile duct). The marked structure in the image is not the lesser omentum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Greater omentum</strong>: This is a large apron-like fold of visceral peritoneum that hangs down from the greater curvature of the stomach. It covers the intestines but is not the structure marked in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The lienorenal ligament is a peritoneal structure connecting the spleen to the kidney and contains the splenic artery. This ligament is essential for surgeons to identify, especially during procedures involving the spleen or splenic artery.</span></p>",
      "correct_choice_id": 221597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6517,
      "choices": [
        {
          "id": 26037,
          "text": "<p><span style=\"font-size:12.0pt;\">Naproxen</span></p>"
        },
        {
          "id": 26038,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 26039,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 26040,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with chronic kidney disease underwent nephrectomy. Which of the following can be administered as a postoperative analgesic in this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q3841196",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021146,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Acetaminophen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with chronic kidney disease (CKD), nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen, indomethacin, and diclofenac are generally avoided due to their potential to worsen renal function. These medications inhibit prostaglandin synthesis, which can lead to renal vasoconstriction and further decline in kidney function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen (paracetamol), on the other hand, is generally considered safer for patients with CKD when used at appropriate doses. It has a different mechanism of action (inhibit COX3) and does not significantly affect renal hemodynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Naproxen: </strong>Naproxen is an NSAID that can significantly impair renal function, especially in patients with pre-existing kidney disease. It should be avoided in this population due to the risk of worsening kidney function and potential for causing renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Indomethacin: </strong>Indomethacin is another NSAID with similar risks to naproxen. Its use can lead to decreased renal perfusion and exacerbate renal impairment, making it unsuitable for patients with CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diclofenac: </strong>Diclofenac, like other NSAIDs, poses a significant risk to kidney function in patients with CKD. It can reduce prostaglandin synthesis, leading to renal vasoconstriction and further renal impairment, and should be avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen is the preferred postoperative analgesic for patients with chronic kidney disease, as it does not significantly affect renal function and is safer than NSAIDs in this population.</span></p>",
      "correct_choice_id": 26040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80065,
      "choices": [
        {
          "id": 318976,
          "text": "<p><span style=\"font-size:12.0pt;\">Heerfordt Syndrome&nbsp;</span></p>"
        },
        {
          "id": 318977,
          "text": "<p><span style=\"font-size:12.0pt;\">Ramsay Hunt Syndrome&nbsp;</span></p>"
        },
        {
          "id": 318978,
          "text": "<p><span style=\"font-size:12.0pt;\">Bell’s Palsy</span></p>"
        },
        {
          "id": 318979,
          "text": "<p><span style=\"font-size:12.0pt;\">Melkersson's Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which condition is characterized by facial palsy due to herpes infection involving the geniculate ganglion? (NEET PG 2017)</span></p>",
      "unique_key": "Q1197024",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021137,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ramsay Hunt Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ramsay Hunt Syndrome is characterized by facial palsy due to herpes zoster infection (varicella-zoster virus) involving the geniculate ganglion of the facial nerve. It presents as a triad of facial nerve palsy, vesicular eruptions on the pinna and external auditory canal, and vestibulocochlear symptoms. The infection represents a reactivation of the herpes zoster virus that had remained dormant in the geniculate ganglion after previous chickenpox infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heerfordt Syndrome</strong>: This is a rare manifestation of sarcoidosis characterized by the triad of uveitis, parotid gland enlargement, and facial nerve palsy. It is not related to herpes infection of the geniculate ganglion. The facial palsy in this condition is due to granulomatous infiltration of the facial nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bell's Palsy</strong>: While this is also a facial nerve paralysis, Bell's palsy is idiopathic in nature. Although some theories suggest that herpes simplex virus may be involved in some cases of Bell's palsy, it does not specifically involve vesicular eruptions or definitive evidence of geniculate ganglion involvement as seen in Ramsay Hunt Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Melkersson's Syndrome</strong>: This syndrome (also called Melkersson-Rosenthal syndrome) is characterized by recurrent or persistent facial swelling, recurrent facial paralysis, and a fissured tongue (lingua plicata). It is not caused by herpes infection of the geniculate ganglion but is thought to be related to granulomatous disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ramsay Hunt Syndrome is specifically characterized by facial nerve palsy due to herpes zoster infection of the geniculate ganglion, presenting with the distinctive triad of facial paralysis, ear/mouth vesicles, and auditory/vestibular symptoms.</span></p>",
      "correct_choice_id": 318977,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80070,
      "choices": [
        {
          "id": 318996,
          "text": "<p><span style=\"font-size:12.0pt;\">Tullio Phenomenon</span></p>"
        },
        {
          "id": 318997,
          "text": "<p><span style=\"font-size:12.0pt;\">Hennebert’s Sign</span></p>"
        },
        {
          "id": 318998,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll-over Phenomenon</span></p>"
        },
        {
          "id": 318999,
          "text": "<p><span style=\"font-size:12.0pt;\">Recruitment Phenomenon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which phenomenon describes vertigo induced by loud sounds?&nbsp;(NEET PG 2017)</span></p>",
      "unique_key": "Q5580649",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021353,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tullio Phenomenon</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tullio phenomenon refers to the development of vertigo and nystagmus in response to loud sounds. This occurs due to a pathological connection between the sound-conducting system and the vestibular apparatus. Loud sounds cause abnormal stimulation of the vestibular system, resulting in vestibular symptoms. This phenomenon is seen in conditions like superior semicircular canal dehiscence, perilymphatic fistula, and advanced otosyphilis where there is an abnormal communication between the inner ear fluid compartments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hennebert's Sign</strong>: This refers to the development of vertigo and nystagmus on applying pressure to the external auditory canal (positive fistula test) in the absence of a demonstrable fistula (false positive). It is typically seen in congenital syphilis due to the presence of fibrous adhesions between the stapes footplate and the membranous labyrinth. Unlike Tullio phenomenon which is triggered by sound, Hennebert's sign is elicited by pressure changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Roll-over Phenomenon</strong>: This is seen in retrocochlear hearing loss (e.g., acoustic neuroma). It refers to a decrease in speech discrimination scores as the intensity of sound is increased beyond a certain level. Unlike Tullio phenomenon, it does not involve vertigo and is related to hearing discrimination rather than vestibular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Recruitment Phenomenon</strong>: This is the abnormal growth of loudness perception seen in cochlear hearing loss. Patients with cochlear lesions have difficulty hearing soft sounds, but as intensity increases, they perceive loudness as rapidly growing to normal or even uncomfortable levels. This phenomenon affects hearing rather than balance and does not cause vertigo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tullio phenomenon specifically describes the vestibular symptoms (vertigo and nystagmus) induced by loud sounds due to pathological communication between the sound-conducting and vestibular systems of the inner ear.</span></p>",
      "correct_choice_id": 318996,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80109,
      "choices": [
        {
          "id": 319152,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Syncytial Virus</span></p>"
        },
        {
          "id": 319153,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza</span></p>"
        },
        {
          "id": 319154,
          "text": "<p><span style=\"font-size:12.0pt;\">Parainfluenza</span></p>"
        },
        {
          "id": 319155,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus Pneumoniae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which virus is the most common cause of croup in children? (NEET PG 2016)</span></p>",
      "unique_key": "Q9167287",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021136,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Parainfluenza&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parainfluenza virus (especially types 1 and 2) is the most common cause of croup in children, accounting for approximately 75% of all cases. Croup, also known as laryngotracheobronchitis, is characterized by barky cough, hoarseness, and inspiratory stridor resulting from inflammation and narrowing of the subglottic area. Parainfluenza virus causes inflammation and edema of the larynx, trachea, and bronchi, with the narrowest portion of the pediatric airway (subglottic region) being particularly affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Respiratory Syncytial Virus (RSV)</strong> - Incorrect. RSV is the leading cause of bronchiolitis in children under 2 years of age, but it is not the primary causative agent of croup. RSV affects the lower respiratory tract, causing inflammation of the small airways (bronchioles).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Influenza</strong> - Incorrect. While influenza can cause croup-like symptoms, it is not the most common viral cause. Influenza typically causes more systemic symptoms like high fever, myalgia, and fatigue in addition to respiratory symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Streptococcus Pneumoniae</strong> - Incorrect. This is a bacterium, not a virus. Streptococcus pneumoniae is a major cause of bacterial pneumonia, otitis media, and sinusitis, but not typically associated with croup, which is predominantly viral in etiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parainfluenza virus is the most common cause of viral croup in children, typically presenting with the classic triad of barky cough, inspiratory stridor, and hoarseness, with symptoms often worsening at night.</span></p>",
      "correct_choice_id": 319154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55534,
      "choices": [
        {
          "id": 221589,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalamus</span></p>"
        },
        {
          "id": 221590,
          "text": "<p><span style=\"font-size:12.0pt;\">Lentiform nucleus</span></p>"
        },
        {
          "id": 221591,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate</span></p>"
        },
        {
          "id": 221592,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal capsule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-100505.png\" alt=\"\" width=\"300\" height=\"284\"></span></p>",
      "unique_key": "Q2315588",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021054,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Internal capsule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The internal capsule is a white matter structure situated between the thalamus and the lentiform nucleus. It contains important pathways that carry motor and sensory information to and from the cerebral cortex. In the provided image, the marked structure lies outside the thalamus and appears as a bundle of white matter, which is characteristic of the internal capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thalamus</strong>: The thalamus is located medial to the internal capsule and is not the structure marked in the image. The thalamus serves as a relay station for sensory and motor signals to the cerebral cortex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lentiform nucleus</strong>: The lentiform nucleus, which includes the putamen and globus pallidus, is situated lateral to the internal capsule. It is not the structure marked in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Caudate</strong>: The caudate nucleus is located superior to the thalamus and medial to the internal capsule. It is also not the structure marked in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The internal capsule is a key white matter structure that lies between the thalamus and the lentiform nucleus, transmitting important motor and sensory pathways to the cerebral cortex.</span></p>",
      "correct_choice_id": 221592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80095,
      "choices": [
        {
          "id": 319096,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper 0.045 mmol/L</span></p>"
        },
        {
          "id": 319097,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium 40 mmol/L</span></p>"
        },
        {
          "id": 319098,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium 65 mmol/L</span></p>"
        },
        {
          "id": 319099,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium 3 mmol/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is NOT true regarding the electrolyte composition of 'ReSoMal' oral rehydration salts solution used for malnourished children? (NEET PG 2015)</span></p>",
      "unique_key": "Q1014331",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021143,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Sodium 65 mmol/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ReSoMal (Rehydration Solution for Malnutrition) is specifically formulated for rehydrating children with severe acute malnutrition (SAM). The sodium content in ReSoMal is 45 mmol/L, not 65 mmol/L as stated in option C. This reduced sodium concentration is intentional because malnourished children have excess body sodium despite presenting with low serum sodium levels. The standard WHO ORS contains 90 mmol/L sodium, which is too high for malnourished children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct composition of ReSoMal includes:</span></p><ul><li><span style=\"font-size:12.0pt;\">Sodium: 45 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Potassium: 40 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Chloride: 70 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Glucose: 125 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Magnesium: 3 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Zinc: 0.3 mmol/L</span></li><li><span style=\"font-size:12.0pt;\">Copper: 0.045 mmol/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Copper 0.045 mmol/L - Correct</strong>. ReSoMal contains copper at a concentration of 0.045 mmol/L, which helps address micronutrient deficiencies common in malnourished children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Potassium 40 mmol/L - Correct</strong>. ReSoMal has increased potassium (40 mmol/L) compared to standard ORS (20 mmol/L) to address potassium depletion in malnourished children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Magnesium 3 mmol/L - Correct</strong>. ReSoMal contains magnesium at 3 mmol/L to help correct magnesium deficiency commonly seen in severe malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ReSoMal has a lower sodium concentration (45 mmol/L) and higher potassium concentration (40 mmol/L) than standard ORS to address the specific electrolyte abnormalities in severe acute malnutrition. This specialized formulation helps prevent complications like heart failure during rehydration therapy in malnourished children.</span></p>",
      "correct_choice_id": 319098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76182,
      "choices": [
        {
          "id": 303601,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Influenza</span></p>"
        },
        {
          "id": 303602,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Varicella</span></p>"
        },
        {
          "id": 303603,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Rabies</span></p>"
        },
        {
          "id": 303604,
          "text": "<p><span style=\"font-size:16px;\">TDaP</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Which of the following vaccines is contraindicated in pregnancy?&nbsp;(FMGE JAN 2025)</span></p>",
      "unique_key": "Q1359304",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021055,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans.&nbsp;B) Varicella</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Live attenuated vaccines are contraindicated in pregnancy</strong> because pregnancy is an immunocompromised state. Among the given options, <strong>Varicella (chickenpox) vaccine is a live attenuated vaccine and therefore contraindicated during pregnancy.&nbsp;</strong>This is due to the theoretical risk of transmission of the attenuated virus to the fetus, which could potentially cause harm.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option A. Influenza:&nbsp;</strong>Incorrect because it is an inactivated vaccine and is actually recommended during pregnancy to protect both mother and baby.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Rabies:&nbsp;</strong>Incorrect because it is a killed vaccine and can be safely administered during pregnancy if indicated.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. TDaP:&nbsp;</strong>Incorrect because it is a toxoid/inactivated vaccine and is recommended during pregnancy to provide passive immunity to the newborn.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Live attenuated vaccines (like Varicella, MMR, Yellow fever) are contraindicated during pregnancy, while killed/inactivated vaccines and toxoids are safe and often recommended during pregnancy.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">CONTRAINDICATIONS, AEFI</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Contraindications</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_X2KmTvx.png\" width=\"1013\" height=\"697\"></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_99vK8ud.png\" width=\"524\" height=\"424\"></p>",
      "correct_choice_id": 303602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57299,
      "choices": [
        {
          "id": 228573,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atorvastatin</span></span></p>"
        },
        {
          "id": 228574,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fenofibrate</span></span></p>"
        },
        {
          "id": 228575,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinamide</span></span></p>"
        },
        {
          "id": 228576,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ezetimibe</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient being treated for hypertriglyceridemia developed flushing, gout, hyperglycemia, and raised liver enzymes. Which drug is the most likely cause? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q3717483",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Nicotinamide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinamide, also known as niacin, is a lipid-lowering agent commonly used in the treatment of hypertriglyceridemia. However, it is associated with several side effects that can limit its use. The <strong>most common and characteristic side effect of niacin is flushing, which is caused by the release of prostaglandins. </strong>This flushing can be intense and uncomfortable for patients, often leading to discontinuation of the drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition to flushing, niacin can cause <strong>hyperuricemia,</strong> which may precipitate gout, and it can also lead to <strong>hyperglycemia and insulin resistance</strong>. Furthermore, niacin is <strong>hepatotoxic</strong>, which can manifest as elevated liver enzymes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While statins can also cause hyperglycemia and hepatotoxicity, they do not cause the flushing or gout that are characteristic of niacin use. <strong>Statins are more commonly associated with myopathy,</strong> which is not a feature in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atorvastatin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While atorvastatin, a statin, can cause hyperglycemia and raised liver enzymes, it is not typically associated with flushing or gout. Myopathy is the more significant side effect with statins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fenofibrate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fenofibrate, used to treat hypertriglyceridemia, may cause elevated liver enzymes and, rarely, hyperuricemia, but it is not associated with flushing or significant hyperglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ezetimibe</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ezetimibe is a cholesterol absorption inhibitor that is generally well tolerated and is not associated with the side effects of flushing, gout, or hyperglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinamide (niacin) is associated with flushing, gout, hyperglycemia, and raised liver enzymes, making it the likely cause of these symptoms in a patient being treated for hypertriglyceridemia</span></span></span></p>",
      "correct_choice_id": 228575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80063,
      "choices": [
        {
          "id": 318968,
          "text": "<p><span style=\"font-size:12.0pt;\">Stenger’s Test</span></p>"
        },
        {
          "id": 318969,
          "text": "<p><span style=\"font-size:12.0pt;\">Fowler Test</span></p>"
        },
        {
          "id": 318970,
          "text": "<p><span style=\"font-size:12.0pt;\">Lombard’s Test</span></p>"
        },
        {
          "id": 318971,
          "text": "<p><span style=\"font-size:12.0pt;\">Erhardt’s Test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests is not used for assessing non-organic hearing loss?&nbsp;(NEET PG 2017)</span></p>",
      "unique_key": "Q9080892",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Fowler Test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fowler Test (Alternate Binaural Loudness Balance Test) is not used for diagnosing non-organic hearing loss. It is specifically designed to detect and measure recruitment in unilateral sensorineural hearing loss. In this test, tones of the same frequency but different intensities are presented alternately to both ears, and the patient is asked to compare loudness. The test helps identify cochlear pathology by demonstrating recruitment phenomenon, where sounds that are barely audible reach uncomfortable loudness with small increases in intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stenger's Test</strong>: This is correctly used for detecting non-organic hearing loss, particularly unilateral feigned hearing loss. It employs the principle that when tones of different intensities are presented simultaneously to both ears, only the louder tone is perceived. If a patient with claimed unilateral deafness denies hearing a tone presented to both ears (with the \"deaf\" ear receiving a stronger stimulus), malingering is confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lombard's Test</strong>: This is correctly used to detect non-organic hearing loss. It relies on the principle that people unconsciously raise their voice when they cannot hear themselves speak. In this test, the patient is asked to read aloud while noise is introduced to their ears. A genuine hearing-impaired person will raise their voice, while a malingerer maintaining normal voice level reveals non-organic hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Erhardt's Test</strong>: This is correctly used for detecting non-organic hearing loss. It employs tuning forks that appear identical but vibrate at different frequencies. The patient is shown which fork corresponds to which tone but cannot actually see which fork is being used in testing. Inconsistent responses reveal the non-organic nature of the hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Fowler Test (ABLB) is designed specifically to detect recruitment in sensorineural hearing loss, particularly of cochlear origin, and is not part of the standard test battery for identifying non-organic hearing loss or malingering.</span></p>",
      "correct_choice_id": 318969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44816,
      "choices": [
        {
          "id": 178911,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuretics- Collecting duct</span></p>"
        },
        {
          "id": 178912,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic anhydrase inhibitors-Proximal tubule</span></p>"
        },
        {
          "id": 178913,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides-Loop of Henle</span></p>"
        },
        {
          "id": 178914,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone antagonists- early Distal tubules</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following diuretic is correctly matched with its site of action (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20132839.jpg\" width=\"783\" height=\"265\"></p>",
      "unique_key": "Q6819023",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021049,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Carbonic anhydrase inhibitors - Proximal tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Carbonic anhydrase inhibitors</strong> - These act in the <strong>proximal tubule</strong>. Acetazolamide is a commonly used carbonic anhydrase inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Osmotic diuretics- Collecting duct:</strong></span><span style=\"font-size:12pt;\"><strong> </strong>These work primarily in the <strong>proximal tubule</strong> and the <strong>descending limb of the loop of Henle</strong>, not the collecting duct. Mannitol is a common example.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Thiazides-Loop of Henle:</strong></span><span style=\"font-size:12pt;\"><strong> </strong>These primarily act on the <strong>distal convoluted tubule</strong>. Hydrochlorothiazide is a typical example.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Aldosterone antagonists- early&nbsp;Distal tubules:</strong></span><span style=\"font-size:12pt;\"> These work in the <strong>collecting ducts and late distal tubules</strong>. Spironolactone is a well-known aldosterone antagonist.</span></p>",
      "correct_choice_id": 178912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80068,
      "choices": [
        {
          "id": 318988,
          "text": "<p><span style=\"font-size:12.0pt;\">16 mm</span></p>"
        },
        {
          "id": 318989,
          "text": "<p><span style=\"font-size:12.0pt;\">20 mm</span></p>"
        },
        {
          "id": 318990,
          "text": "<p><span style=\"font-size:12.0pt;\">24 mm</span></p>"
        },
        {
          "id": 318991,
          "text": "<p><span style=\"font-size:12.0pt;\">28 mm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the length of the external auditory canal in an adult? (NEET PG 2017)</span></p>",
      "unique_key": "Q5752767",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021145,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 24 mm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The external auditory canal in an adult measures about 24 mm along its posterior wall. This is the standard anatomical length of the external auditory canal. The canal is not straight but has a slight S-shape, with the outer part directed upwards, backwards, and medially, while the inner part is directed downwards, forwards, and medially.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 16 mm</strong>: This is incorrect for the total length of the external auditory canal. However, 16 mm specifically represents the length of the bony part of the external auditory canal, which forms the inner two-thirds of the total canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 20 mm</strong>: This is incorrect. The external auditory canal is longer than 20 mm in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 28 mm</strong>: This is incorrect. The external auditory canal is shorter than 28 mm in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The external auditory canal in adults measures approximately 24 mm along its posterior wall and consists of a cartilaginous part (outer one-third, approximately 8 mm) and a bony part (inner two-thirds, approximately 16 mm).</span></p>",
      "correct_choice_id": 318990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80110,
      "choices": [
        {
          "id": 319156,
          "text": "<p><span style=\"font-size:12.0pt;\">Measles</span></p>"
        },
        {
          "id": 319157,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 319158,
          "text": "<p><span style=\"font-size:12.0pt;\">RSV</span></p>"
        },
        {
          "id": 319159,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Hecht's Pneumonia is typically associated with which of the following infections? (NEET PG 2016)</span></p>",
      "unique_key": "Q2836770",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021144,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Measles&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hecht's pneumonia refers to the giant cell pneumonia that occurs as a complication of measles infection. It is characterized by the presence of multinucleated giant cells (Warthin-Finkeldey cells) in the lung tissue, which are pathognomonic for measles. This form of pneumonia represents a serious complication of measles and is associated with significant morbidity and mortality. Measles virus directly infects the respiratory epithelium, leading to necrosis and the formation of these characteristic giant cells in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Malaria</strong> - Incorrect. Malaria is a parasitic infection caused by Plasmodium species transmitted by mosquitoes. While it can cause pulmonary complications (particularly P. falciparum), it does not cause Hecht's pneumonia or the formation of multinucleated giant cells in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. RSV</strong> - Incorrect. Respiratory Syncytial Virus causes bronchiolitis and pneumonia, especially in young children, but is not associated with Hecht's pneumonia or giant cell formation. RSV typically causes inflammation of the bronchioles with mucus plugging and epithelial cell necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pneumococcus</strong> - Incorrect. Streptococcus pneumoniae is a common bacterial cause of community-acquired pneumonia in all age groups, but causes a lobar pneumonia pattern with neutrophilic infiltration, not giant cell pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hecht's pneumonia (giant cell pneumonia) is a specific and severe complication of measles infection, characterized by the pathognomonic Warthin-Finkeldey giant cells in lung tissue, and represents one of the serious complications that can occur with measles.</span></p>",
      "correct_choice_id": 319156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80139,
      "choices": [
        {
          "id": 319272,
          "text": "<p><span style=\"font-size:12.0pt;\">It is the most common cause of Nephrotic Syndrome in children.</span></p>"
        },
        {
          "id": 319273,
          "text": "<p><span style=\"font-size:12.0pt;\">The prognosis is generally good.</span></p>"
        },
        {
          "id": 319274,
          "text": "<p><span style=\"font-size:12.0pt;\">Initial management typically involves prednisolone at 60 mg/day.</span></p>"
        },
        {
          "id": 319275,
          "text": "<p><span style=\"font-size:12.0pt;\">Remission is indicated by a urine protein: creatinine ratio &gt;2.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Minimal Change Disease (MCD) is INCORRECT? (NEET PG 2017)</span></p>",
      "unique_key": "Q8636590",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021481,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Remission is indicated by a urine protein: creatinine ratio &gt;2.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Remission in minimal change disease is indicated by a urine protein: creatinine ratio &lt;0.2 (not &gt;2). Remission is defined as \"urine albumin nil or trace (or proteinuria &lt;4 mg/m²/hr) for 3 consecutive early morning specimens.\" A protein ratio &gt;2 would actually indicate heavy proteinuria of nephrotic range proteinuria, not remission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Remission criteria are specifically defined as early morning urine showing protein nil/trace for 3 consecutive days or proteinuria &lt;4 mg/m²/hr. A ratio &gt;2 would indicate ongoing disease activity rather than resolution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. Minimal change disease (MCD) is indeed the most common cause of nephrotic syndrome in children, accounting for approximately 90% of cases of idiopathic nephrotic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. The prognosis of minimal change disease is generally good, with &gt;95% of patients responding to steroid therapy. Most patients outgrow the condition by adulthood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Initial management involves prednisolone at a dose of 2 mg/kg/day (maximum 60 mg) for 6 weeks followed by alternate day therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Remission in nephrotic syndrome is defined by the absence of proteinuria (nil/trace) for 3 consecutive days or proteinuria &lt;4 mg/m²/hr, while a urine protein ratio &gt;2 indicates ongoing heavy proteinuria, not remission.</span></p>",
      "correct_choice_id": 319275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55538,
      "choices": [
        {
          "id": 221605,
          "text": "<p><span style=\"font-size:12.0pt;\">Arch of aorta</span></p>"
        },
        {
          "id": 221606,
          "text": "<p><span style=\"font-size:12.0pt;\">Ductus arteriosus</span></p>"
        },
        {
          "id": 221607,
          "text": "<p><span style=\"font-size:12.0pt;\">Subclavian artery</span></p>"
        },
        {
          "id": 221608,
          "text": "<p><span style=\"font-size:12.0pt;\">Common carotid artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which structure develops from the 6th pharyngeal arch artery on the left side?&nbsp;(FMGE JULY 2024)</span></p>",
      "unique_key": "Q7156278",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021357,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ductus arteriosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The 6th pharyngeal arch artery plays a crucial role in embryonic development, particularly in forming structures related to the circulatory system. On the left side, the distal part of the 6th pharyngeal arch artery develops into the ductus arteriosus, a vital fetal blood vessel that allows blood to bypass the lungs, which are not yet functional before birth. After birth, the ductus arteriosus normally closes and becomes the ligamentum arteriosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/whatsapp-image-2024-08-31-at-100108-am.jpeg\" alt=\"\" width=\"500\" height=\"465\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Arch of aorta:</strong> The arch of the aorta is primarily derived from the left 4th pharyngeal arch artery, not the 6th.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subclavian artery:</strong> The right subclavian artery is derived from the right 4th pharyngeal arch artery and other structures, while the left subclavian artery arises from the left 7th intersegmental artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Common carotid artery:</strong> The common carotid artery primarily arises from the 3rd pharyngeal arch artery, not the 6th.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ductus arteriosus, a critical structure in fetal circulation, develops from the distal part of the 6th pharyngeal arch artery on the left side.</span></p>",
      "correct_choice_id": 221606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6532,
      "choices": [
        {
          "id": 26097,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits the release of acetylcholine</span></p>"
        },
        {
          "id": 26098,
          "text": "<p><span style=\"font-size:12.0pt;\">Release of noradrenaline at synaptic cleft</span></p>"
        },
        {
          "id": 26099,
          "text": "<p><span style=\"font-size:12.0pt;\">Selectively and irreversibly inhibits nicotinic receptors</span></p>"
        },
        {
          "id": 26100,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates muscarinic and nicotinic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman received a Botox injection for the treatment of wrinkles.&nbsp; Which of the following is the mechanism of action of botulinum toxin?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q6232382",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021139,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inhibits the release of acetylcholine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The botulinum toxin works by preventing acetylcholine from entering the synaptic cleft. Acetylcholine is exocytosed by SNARE protein, which is broken down by botulinum toxin. Consequently, it prevents acetylcholine from being released.</span></li><li><span style=\"font-size:12.0pt;\">Other agents that regulate the level of Ach in the synapse are:</span><ul><li><span style=\"font-size:12.0pt;\">Hemicholinium acts by inhibiting choline uptake (the rate limiting step in the synthesis of acetylcholine)</span></li><li><span style=\"font-size:12.0pt;\">Vesamicol inhibits the uptake of Acetylcholine into the vesicles.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine inhibits the breakdown of Ach at the synaptic cleft by the action of Acetylcholine esterase.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Release of noradrenaline at synaptic cleft:&nbsp;</strong>Botulinum toxin does not facilitate the release of noradrenaline. Its primary action is on the cholinergic neurons where it inhibits the release of acetylcholine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Selectively and irreversibly inhibits nicotinic receptors:&nbsp;</strong>Botulinum toxin does not directly inhibit nicotinic receptors. Instead, it prevents the release of acetylcholine, which means there is no neurotransmitter available to bind to and activate the nicotinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stimulates muscarinic and nicotinic receptors:&nbsp;</strong>Botulinum toxin does not stimulate muscarinic or nicotinic receptors. In fact, it decreases neurotransmission by preventing the release of acetylcholine, which would otherwise stimulate these receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin inhibits the release of acetylcholine by cleaving SNARE proteins, thereby preventing neurotransmission at the neuromuscular junction and leading to muscle relaxation.</span></p>",
      "correct_choice_id": 26097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6519,
      "choices": [
        {
          "id": 26045,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-6</span></p>"
        },
        {
          "id": 26046,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-2</span></p>"
        },
        {
          "id": 26047,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-4</span></p>"
        },
        {
          "id": 26048,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of rheumatoid arthritis is not responding well to conventional treatment. Her rheumatologist is considering adding tocilizumab to her treatment regimen. Which of the following interleukins (IL) is primarily targeted by tocilizumab? (NEET PG 2021)</span></p>",
      "unique_key": "Q7349502",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021482,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IL-6</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tocilizumab is a monoclonal antibody that specifically targets and inhibits the interleukin-6 (IL-6) receptor. By blocking the IL-6 receptor, tocilizumab interrupts the signaling pathway of IL-6, a cytokine involved in the inflammatory response. This is particularly beneficial in conditions like rheumatoid arthritis, where elevated levels of IL-6 contribute to the inflammatory process.</span></li><li><span style=\"font-size:12.0pt;\">Tocilizumab has also been used in COVID-19 for cytokine release syndrome.</span></li><li><span style=\"font-size:12.0pt;\">It is avoided in patients with liver disease, immunosuppression, having a high risk of GIT perforation, Absolute Neutrophil Count &lt;500 cell/µl and Platelet count &lt;50000 cells/µl.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IL-2</strong>: Drugs like basiliximab or daclizumab are used to target IL-2 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IL-4</strong>: Dupilumab is an example of a medication that targets IL-4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IL-5</strong>: Mepolizumab and reslizumab are examples of medications that target IL-5.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tocilizumab targets the IL-6 receptor, making it effective for managing rheumatoid arthritis and certain other inflammatory conditions by inhibiting the IL-6 signaling pathway.</span></p>",
      "correct_choice_id": 26045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80107,
      "choices": [
        {
          "id": 319144,
          "text": "<p><span style=\"font-size:12.0pt;\">Moaning Cry</span></p>"
        },
        {
          "id": 319145,
          "text": "<p><span style=\"font-size:12.0pt;\">Red-Haired Boy</span></p>"
        },
        {
          "id": 319146,
          "text": "<p><span style=\"font-size:12.0pt;\">Mosaic Dermatitis</span></p>"
        },
        {
          "id": 319147,
          "text": "<p><span style=\"font-size:12.0pt;\">All Skin and Bone Appearance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Kwashiorkor is not true? (NEET PG 2016)</span></p>",
      "unique_key": "Q6595862",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. All Skin and Bone Appearance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kwashiorkor is a form of severe acute malnutrition primarily due to protein deficiency while maintaining relatively adequate caloric intake. The \"all skin and bone appearance\" is characteristic of marasmus, not kwashiorkor. Children with kwashiorkor typically have edema that masks the muscle wasting, giving them a falsely \"plump\" appearance. They have a distended abdomen, edema (especially of the feet and legs), and fatty liver due to decreased lipoprotein production and transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Moaning Cry</strong> - This is a true feature of kwashiorkor. Children with kwashiorkor often have a characteristic plaintive, moaning cry due to general irritability and weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Red-Haired Boy</strong> - This is a true feature. Kwashiorkor causes depigmentation of hair, leading to reddish or yellowish discoloration (flag sign), particularly noticeable in children with naturally dark hair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mosaic Dermatitis</strong> - This is a true feature of kwashiorkor. Also called \"flaky paint dermatosis,\" the skin develops patches that crack and peel, particularly in areas exposed to repeated friction or pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kwashiorkor is characterized by edema, red/blonde hair discoloration, irritability, and mosaic dermatosis, while the \"all skin and bone\" appearance is typical of marasmus due to calorie deficiency with relative sparing of protein.</span></p>",
      "correct_choice_id": 319147,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76192,
      "choices": [
        {
          "id": 303641,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">6 weeks, 10 weeks, 14 weeks</span></p>"
        },
        {
          "id": 303642,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">At birth, 6 weeks, 10 weeks, 14 weeks, 16-24 months, 5 years</span></p>"
        },
        {
          "id": 303643,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">At birth, 6 weeks, 10 weeks, 14 weeks</span></p>"
        },
        {
          "id": 303644,
          "text": "<p><span style=\"font-size:16px;\">6 weeks, 14 weeks, 9 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the f-IPV dose schedule under the National Immunization Schedule of India? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q1051895",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. D) 6 weeks, 14 weeks, 9 months</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Under the National Immunization Schedule of India, fractional IPV (f-IPV) is given in three doses:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>First dose at 6 weeks</strong></span></li><li><span style=\"font-size:16px;\"><strong>Second dose at 14 weeks (no dose at 10 weeks)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Third dose at 9 months</strong></span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The fractional IPV (f-IPV) schedule in India's National Immunization Schedule consists of three doses at <strong>6 weeks, 14 weeks, and 9 months.</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GjgAjI5.png\" width=\"1101\" height=\"419\"></strong></span></p>",
      "correct_choice_id": 303644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20918,
      "choices": [
        {
          "id": 83636,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine toxicity</span></p>"
        },
        {
          "id": 83637,
          "text": "<p><span style=\"font-size:12.0pt;\">Side effect of pralidoxime</span></p>"
        },
        {
          "id": 83638,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to organophosphate poisoning</span></p>"
        },
        {
          "id": 83639,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to the casualty with organophosphate poisoning. He was started on atropine infusion and pralidoxime. After 2 hours, the patient had a sudden rise in temperature. What is the likely cause of fever? (NEET PG 2023)</span></p>",
      "unique_key": "Q1989425",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021052,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Atropine toxicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely cause of fever in this patient is atropine toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario is of organophosphate poisoning and patient was started on atropine infusion and pralidoxime.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine is a non-specific muscarinic receptor blocker, but not the nicotinic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A/E of Atropine include –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">↑body temperature (due to ↓sweating)</span></li><li><span style=\"font-size:12.0pt;\">↑ HR</span></li><li><span style=\"font-size:12.0pt;\">Dry mouth, Dry &amp; flushed skin</span></li><li><span style=\"font-size:12.0pt;\">Cycloplegia</span></li><li><span style=\"font-size:12.0pt;\">Constipation</span></li><li><span style=\"font-size:12.0pt;\">Disorientation</span></li><li><span style=\"font-size:12.0pt;\">Can cause acute angle-closure glaucoma in older adults (due to mydriasis)</span></li><li><span style=\"font-size:12.0pt;\">Urinary retention in men with prostatic hyperplasia</span></li><li><span style=\"font-size:12.0pt;\">Hyperthermia in infants</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pralidoxime is given as an adjuvant to atropine in cases of organophosphate poisoning. It&nbsp;does not increase body temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, the sudden rise in body temperature is most likely attributed to Atropine Toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Side effect of pralidoxime: </strong>Pralidoxime is used as an adjuvant in the treatment of organophosphate poisoning to reactivate acetylcholinesterase. It does not typically cause hyperthermia or significantly affect body temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Due to organophosphate poisoning:&nbsp;</strong>Organophosphate poisoning typically causes symptoms due to excessive acetylcholine, such as sweating, salivation, bronchorrhea, bradycardia, and muscle fasciculations. It does not typically cause a sudden rise in temperature as described in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Idiopathic:&nbsp;</strong>An idiopathic cause is one that arises spontaneously or for which the cause is unknown. Given the context of the medication administration and known side effects, the fever is more likely due to atropine toxicity rather than an unexplained cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture5.jpg\" alt=\"\" width=\"602\" height=\"488\"></span></p>",
      "correct_choice_id": 83636,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80094,
      "choices": [
        {
          "id": 319092,
          "text": "<p><span style=\"font-size:12.0pt;\">Gabapentin</span></p>"
        },
        {
          "id": 319093,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium Valproate</span></p>"
        },
        {
          "id": 319094,
          "text": "<p><span style=\"font-size:12.0pt;\">Barbiturates</span></p>"
        },
        {
          "id": 319095,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which medication is considered the drug of choice for Benign Rolandic Epilepsy? (NEET PG 2015)</span></p>",
      "unique_key": "Q5910744",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021135,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Sodium Valproate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Benign Rolandic Epilepsy, also known as Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS), is one of the most common childhood epilepsy syndromes. Sodium valproate is considered the drug of choice for this condition due to its broad spectrum antiepileptic properties and effectiveness in controlling both partial and generalized seizures. It works by increasing brain levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Benign Rolandic Epilepsy typically presents with focal seizures involving the face, particularly during sleep, and has a characteristic EEG pattern with centrotemporal spikes. The condition is self-limiting and generally resolves by adolescence, but antiepileptic therapy may be needed during the active phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gabapentin - Incorrect</strong>. While gabapentin is used as an anticonvulsant, it is not the first-line therapy for Benign Rolandic Epilepsy. It is more commonly used for neuropathic pain and as adjunctive therapy for partial seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Barbiturates - Incorrect</strong>. Barbiturates are older generation antiepileptic drugs with significant side effects including sedation and cognitive impairment. They are rarely used as first-line therapy for childhood epilepsies today.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenytoin - Incorrect</strong>. Phenytoin is primarily effective against generalized tonic-clonic and partial seizures but is not the drug of choice for Benign Rolandic Epilepsy due to its side effect profile and pharmacokinetic variability in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium valproate is the preferred first-line treatment for Benign Rolandic Epilepsy due to its efficacy and relatively favorable side effect profile compared to other antiepileptic medications in children.</span></p>",
      "correct_choice_id": 319093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80113,
      "choices": [
        {
          "id": 319168,
          "text": "<p><span style=\"font-size:12.0pt;\">Patent Ductus Arteriosus (PDA)</span></p>"
        },
        {
          "id": 319169,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial Septal Defect (ASD)</span></p>"
        },
        {
          "id": 319170,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetralogy of Fallot (TOF)</span></p>"
        },
        {
          "id": 319171,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrioventricular Septal Defect (AVSD)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which congenital heart disease is most commonly associated with Down's Syndrome? (NEET PG 2016)&nbsp;</span></p>",
      "unique_key": "Q1397852",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021360,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Atrioventricular Septal Defect (AVSD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atrioventricular Septal Defect (AVSD), also known as endocardial cushion defect or atrioventricular canal defect, is the most commonly associated congenital heart defect in Down syndrome (Trisomy 21). About 40-60% of children with Down syndrome have congenital heart disease, and AVSD is the most specific cardiac anomaly, accounting for approximately 30-40% of these cardiac defects. AVSD occurs due to failure of proper development of the endocardial cushions, which are essential for the formation of the lower portion of the atrial septum, the upper portion of the ventricular septum, and the mitral and tricuspid valves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Patent Ductus Arteriosus (PDA)</strong> - Incorrect. While PDA can occur in Down syndrome, it is not the most common or specific cardiac defect associated with the condition. PDA represents failure of the fetal connection between the aorta and pulmonary artery to close after birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atrial Septal Defect (ASD)</strong> - Incorrect. Ostium secundum ASD is common in Down syndrome but not as specific or prevalent as AVSD. The ostium primum type of ASD is actually part of the AVSD spectrum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tetralogy of Fallot (TOF)</strong> - Incorrect. TOF occurs in approximately 6-8% of Down syndrome patients with cardiac defects but is not the most common cardiac anomaly in this population. TOF is more commonly associated with 22q11 deletion syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atrioventricular Septal Defect (AVSD) is the most common and specific congenital heart defect in Down syndrome, affecting approximately 30-40% of patients with cardiac anomalies due to abnormal development of the endocardial cushions.</span></p>",
      "correct_choice_id": 319171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6530,
      "choices": [
        {
          "id": 26089,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 26090,
          "text": "<p><span style=\"font-size:12.0pt;\">Amphotericin B</span></p>"
        },
        {
          "id": 26091,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 26092,
          "text": "<p><span style=\"font-size:12.0pt;\">Griseofulvin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic patient presented with rhinitis and swelling of the face. Intranasal biopsy revealed the presence of broad-based aseptate hyphae with right-angle branching. There was evidence of vascular invasion. What will be the preferred treatment for this condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q2504228",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021051,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Amphotericin B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and biopsy findings of broad-based aseptate hyphae with right-angle branching and evidence of vascular invasion are characteristic of mucormycosis, a serious fungal infection commonly seen in diabetic patients and other immunocompromised individuals. Amphotericin B is the preferred initial treatment for mucormycosis due to its broad antifungal coverage and effectiveness against Mucorales, the group of fungi responsible for this infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fluconazole</strong>: Fluconazole is an antifungal medication used primarily for Candida and Cryptococcus infections. It is not effective against Mucorales and therefore not suitable for treating mucormycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ketoconazole</strong>: Ketoconazole is another antifungal agent with a broad spectrum of action but has limited use due to its side effects and is not effective against Mucorales, making it inappropriate for mucormycosis treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Griseofulvin</strong>: Griseofulvin is used for dermatophyte infections (e.g., tinea infections) and is not effective against Mucorales. It is not suitable for treating mucormycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment of Mucormycosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mucormycosis is a serious fungal infection that requires prompt and aggressive treatment due to its rapid progression and high mortality rate.</span></li><li><span style=\"font-size:12.0pt;\">The mainstay of treatment is intravenous Amphotericin B, often followed by oral posaconazole or isavuconazole for maintenance therapy.</span></li><li><span style=\"font-size:12.0pt;\">Surgical debridement of infected tissue is frequently necessary.</span></li><li><span style=\"font-size:12.0pt;\">Controlling underlying conditions like diabetes is also crucial in managing mucormycosis.</span></li></ul>",
      "correct_choice_id": 26090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80097,
      "choices": [
        {
          "id": 319104,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        },
        {
          "id": 319105,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratomalacia</span></p>"
        },
        {
          "id": 319106,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D deficiency rickets</span></p>"
        },
        {
          "id": 319107,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Stoss therapy is utilized for the treatment of which condition? (NEET PG 2015)</span></p>",
      "unique_key": "Q2917846",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Vitamin D deficiency rickets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stoss therapy refers to the administration of a large single dose or a few divided doses of vitamin D for the rapid correction of vitamin D deficiency. This therapy is specifically designed for treating nutritional vitamin D deficiency rickets. It typically involves giving a high dose of vitamin D (typically 300,000-600,000 IU) as either a single dose or divided over a few days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The advantages of Stoss therapy include improved compliance (as it requires fewer doses) and rapid correction of deficiency. After the initial high-dose therapy, maintenance doses of vitamin D are continued to prevent recurrence. This approach is particularly useful in situations where compliance with daily supplementation might be challenging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Scurvy</strong> - Incorrect. Scurvy is caused by vitamin C deficiency and is treated with vitamin C supplementation (100-200 mg/day for 3 months), not high-dose vitamin D therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Keratomalacia -</strong> Incorrect. Keratomalacia is a condition resulting from severe vitamin A deficiency affecting the cornea. It requires vitamin A supplementation, not vitamin D. Treatment usually involves 200,000 IU of vitamin A orally on day 1, repeated on day 2 and after 2 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypophosphatemic rickets</strong> - Incorrect. Hypophosphatemic rickets (vitamin D-resistant rickets) is typically hereditary and caused by phosphate wasting, not vitamin D deficiency. It is treated with phosphate supplements and calcitriol, not high-dose vitamin D therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stoss therapy is specifically used for treating vitamin D deficiency rickets with large doses (300,000-600,000 IU) given over a short period, providing rapid correction and improved compliance compared to daily supplementation regimens.</span></p>",
      "correct_choice_id": 319106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55537,
      "choices": [
        {
          "id": 221601,
          "text": "<p><span style=\"font-size:12.0pt;\">Adduction</span></p>"
        },
        {
          "id": 221602,
          "text": "<p><span style=\"font-size:12.0pt;\">Extension</span></p>"
        },
        {
          "id": 221603,
          "text": "<p><span style=\"font-size:12.0pt;\">Flexion</span></p>"
        },
        {
          "id": 221604,
          "text": "<p><span style=\"font-size:12.0pt;\">Abduction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has come to the clinic. Identify the movement being examined in the given image: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-100552.png\" alt=\"\" width=\"300\" height=\"297\"></span></p>",
      "unique_key": "Q7002626",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021149,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Abduction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided depicts a clinical examination known as the Trendelenburg test. This test is used to assess the strength and function of the gluteus medius and minimus muscles, which are responsible for abduction of the thigh. These muscles, innervated by the superior gluteal nerve, stabilize the pelvis during walking by keeping the pelvis level when one leg is lifted off the ground.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-100608.png\" alt=\"\" width=\"500\" height=\"430\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a normal Trendelenburg test, when the patient stands on one leg, the gluteus medius and minimus on the standing leg contract to elevate the pelvis on the opposite side, maintaining balance. If the superior gluteal nerve is damaged or the gluteus medius and minimus muscles are weak or paralyzed, the pelvis drops on the side opposite to the standing leg, indicating a positive Trendelenburg sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Adduction:</strong> Adduction refers to the movement of a limb toward the midline of the body. This is not the movement being assessed in the Trendelenburg test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Extension:</strong> Extension is the straightening movement that increases the angle between body parts, such as straightening the leg at the hip joint. The Trendelenburg test does not assess extension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Flexion:</strong> Flexion refers to bending a joint, decreasing the angle between body parts. The Trendelenburg test is not assessing flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Trendelenburg test assesses the function of the gluteus medius and minimus muscles, which are responsible for abduction of the thigh. A positive Trendelenburg sign indicates weakness or paralysis of these muscles, often due to damage to the superior gluteal nerve.</span></p>",
      "correct_choice_id": 221604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57300,
      "choices": [
        {
          "id": 228577,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astemizole</span></span></p>"
        },
        {
          "id": 228578,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetirizine</span></span></p>"
        },
        {
          "id": 228579,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loratadine</span></span></p>"
        },
        {
          "id": 228580,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promethazine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs, when given with erythromycin, can cause QT prolongation and Torsades de pointes? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q3462979",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021483,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Astemizole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astemizole is an antihistamine that, when combined with enzyme inhibitors such as erythromycin, can lead to QT prolongation. This prolongation of the QT interval on an electrocardiogram can predispose a person to a dangerous arrhythmia known as Torsades de pointes, which can be potentially life-threatening. Astemizole was withdrawn from many markets due to this severe adverse effect when used in combination with other drugs that inhibit its metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs causing QT prolongation if given with erythromycin: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cisapride</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astemizole</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terfinadine</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cetirizine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a second-generation antihistamine that does not have significant interactions leading to QT prolongation or Torsades de pointes when combined with erythromycin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Loratadine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Similar to Cetirizine, Loratadine is another second-generation antihistamine with a better safety profile in terms of cardiac effects. It does not cause QT prolongation or Torsades de pointes in conjunction with erythromycin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Promethazine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although promethazine is an older antihistamine that can have sedative effects, it does not have a strong association with QT prolongation or Torsades de pointes when used with erythromycin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astemizole is a drug that, when taken with erythromycin, can lead to QT prolongation and the serious arrhythmia known as Torsades de pointes. This significant adverse effect led to the withdrawal of Astemizole from the market in many countries.</span></span></span></p>",
      "correct_choice_id": 228577,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6515,
      "choices": [
        {
          "id": 26029,
          "text": "<p><span style=\"font-size:12.0pt;\">Analog of UMP</span></p>"
        },
        {
          "id": 26030,
          "text": "<p><span style=\"font-size:12.0pt;\">Competitive inhibitor of DHFR</span></p>"
        },
        {
          "id": 26031,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks purine synthesis</span></p>"
        },
        {
          "id": 26032,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks pyrimidine synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old male patient is diagnosed with osteosarcoma and is scheduled to undergo chemotherapy as part of his treatment. Methotrexate is included in his chemotherapy regimen. What is the mechanism of action of methotrexate in the treatment of his osteosarcoma? (NEET PG 2021)</span></p>",
      "unique_key": "Q5781822",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021129,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Competitive inhibitor of DHFR.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate has different mechanisms for anticancer activity and for Rheumatoid Arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism in Osteosarcoma (As anticancer drug):</strong> Methotrexate acts as a competitive inhibitor of the enzyme dihydrofolate reductase (DHFR). By inhibiting DHFR, methotrexate interferes with the conversion of dihydrofolate to tetrahydrofolate, an essential cofactor for DNA synthesis. This leads to a decrease in DNA and RNA synthesis, thereby arresting the cell cycle and inhibiting the growth of rapidly dividing cells, such as cancer cells in osteosarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism in Rheumatoid Arthritis (RA):</strong> Methotrexate is used at much lower doses in Rheumatoid Arthritis. In this condition, the major mechanism involves the inhibition of an enzyme called AICAR transformylase, part of the purine synthesis pathway. When AICAR transformylase is inhibited, levels of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulate in the cell. This leads to an inhibition of another enzyme called adenosine deaminase, which is responsible for the degradation of adenosine. As a result, adenosine levels increase within the cell and in the extracellular environment.</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Adenosine is known to have anti-inflammatory properties. When adenosine interacts with its receptors, it can lead to various effects such as inhibition of inflammatory cell function, vasodilation, and reduced pro-inflammatory cytokine release. These actions contribute to the anti-inflammatory effects observed when methotrexate is used for treating RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Analog of UMP</strong>: Methotrexate is not an analog of UMP (uridine monophosphate). It does not exert its effects through this mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Blocks purine synthesis</strong>: Methotrexate does not specifically block purine synthesis, although the inhibition of DHFR indirectly affects purine and pyrimidine synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blocks pyrimidine synthesis</strong>: Similar to Option C, methotrexate does not specifically block pyrimidine synthesis but indirectly affects it through DHFR inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate's primary mechanism of action in treating osteosarcoma is as a competitive inhibitor of dihydrofolate reductase (DHFR), which interferes with DNA synthesis and cell division in rapidly dividing cells.</span></p>",
      "correct_choice_id": 26030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6533,
      "choices": [
        {
          "id": 26101,
          "text": "<p><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
        },
        {
          "id": 26102,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 26103,
          "text": "<p><span style=\"font-size:12.0pt;\">Bempedoic acid</span></p>"
        },
        {
          "id": 26104,
          "text": "<p><span style=\"font-size:12.0pt;\">Clofibrate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a PCSK9 inhibitor?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q2992308",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021147,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Evolocumab</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alirocumab and Evolocumab are PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. These works by inhibiting the PCSK9 enzyme which is responsible for degradation of LDL receptors in the liver. Therefore, these drugs lead to an increased number of low-density lipoprotein (LDL) receptors on liver cells and a subsequent decrease in LDL cholesterol levels in the blood. PCSK9 inhibitors are used for lowering cholesterol levels, particularly in patients with familial hypercholesterolemia or those who are at high risk for cardiovascular disease and have not adequately responded to statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ezetimibe</strong>: Ezetimibe works by inhibiting the absorption of cholesterol in the small intestine, which leads to a reduction in the total amount of cholesterol presented to the liver. It does not inhibit PCSK9.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bempedoic Acid</strong>: Bempedoic acid is a relatively new cholesterol-lowering medication. It inhibits ATP citrate lyase, an enzyme involved in cholesterol synthesis, but it is not a PCSK9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Clofibrate</strong>: Clofibrate is a fibrate used to lower lipid levels, particularly triglycerides. It works by activating peroxisome proliferator-activated receptors (PPARs) and does not inhibit PCSK9.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a PCSK9 inhibitor that works by blocking the PCSK9 enzyme, leading to increased LDL receptor availability on liver cells and reduced LDL cholesterol levels in the blood.</span></p>",
      "correct_choice_id": 26101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57298,
      "choices": [
        {
          "id": 228569,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 228570,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine</span></span></p>"
        },
        {
          "id": 228571,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lisinopril</span></span></p>"
        },
        {
          "id": 228572,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person was taking an antihypertensive drug and continued taking it despite developing constipation, dry mouth, and dizziness. He was taking it regularly but forgot to take it during a trip abroad and has now developed a hypertensive emergency. Which antihypertensive was he likely taking? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q7592388",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021148,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Clonidine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine is an alpha-2 adrenergic agonist used in the management of hypertension. One of the common side effects of Clonidine includes dry mouth, constipation, and dizziness, which matches the symptoms described in this case. Additionally, a significant risk associated with Clonidine is the potential for rebound hypertension if the medication is suddenly discontinued, as can happen if a dose is missed. This rebound effect occurs because the body&#39;s sympathetic nervous system experiences a sudden surge in activity once the inhibitory effects of Clonidine are removed, leading to a hypertensive emergency, as seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember &ndash; Clonidine is safe in Pregnancy&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Amlodipine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine is a calcium channel blocker used for hypertension but does not typically cause rebound hypertension. Its side effects more commonly include peripheral edema rather than the symptoms described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lisinopril:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lisinopril is an ACE inhibitor that does not cause the described side effects of dry mouth, dizziness, and constipation. Additionally, sudden discontinuation of Lisinopril does not lead to a hypertensive emergency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Telmisartan:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan is an angiotensin II receptor blocker (ARB). It generally does not cause dry mouth, constipation, or dizziness, and discontinuation does not lead to rebound hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine is an antihypertensive medication that can cause dry mouth, constipation, and dizziness, and sudden discontinuation can lead to rebound hypertension, making it crucial for patients to maintain consistent dosing.</span></span></span></p>",
      "correct_choice_id": 228570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6531,
      "choices": [
        {
          "id": 26093,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26094,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 26095,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B2</span></p>"
        },
        {
          "id": 26096,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A tuberculosis patient receiving anti-tubercular treatment complains of tingling and paresthesia in the lower limbs. He is not diabetic and drinks alcohol on occasion. Which of the following vitamins should be given to this patient?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q8969848",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021130,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of tingling and paresthesia in the lower limbs, in the context of receiving anti-tubercular treatment, are suggestive of peripheral neuropathy. One of the mainstays of tuberculosis (TB) treatment includes the drug isoniazid, which is known to cause vitamin B6 (pyridoxine) deficiency. Supplementing with vitamin B6 can prevent or alleviate these symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitamin B12</strong>: While vitamin B12 deficiency can cause peripheral neuropathy, it is not typically associated with anti-tubercular therapy. Vitamin B12 deficiency is more commonly linked to conditions like pernicious anemia or dietary deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B2 (Riboflavin):</strong> Deficiency of vitamin B2 can lead to various symptoms, including skin disorders and anemia, but it is not specifically linked to the type of neuropathy seen in patients taking isoniazid for TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B3 (Niacin):</strong> Deficiency of vitamin B3 leads to pellagra, characterized by dermatitis, diarrhea, and dementia, and is not associated with the peripheral neuropathy observed in patients on isoniazid therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients receiving isoniazid as part of anti-tubercular therapy should be supplemented with vitamin B6 (pyridoxine) to prevent or treat peripheral neuropathy, a common side effect of this medication.</span></p>",
      "correct_choice_id": 26093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57295,
      "choices": [
        {
          "id": 228557,
          "text": "<p><span style=\"font-size:12pt;\">It is an Equal Mixture of Local Anesthetics</span></p>"
        },
        {
          "id": 228558,
          "text": "<p><span style=\"font-size:12pt;\">It contains lignocaine and ropivacaine in a ratio of 50 percent each</span></p>"
        },
        {
          "id": 228559,
          "text": "<p><span style=\"font-size:12pt;\">Excessive use can result in methemoglobinemia</span></p>"
        },
        {
          "id": 228560,
          "text": "<p><span style=\"font-size:12pt;\">5 ml of 5 percent mixture contains 50 mg lignocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the patch used in the given figure is correct? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-184820.jpg\" alt=\"\" width=\"400\" height=\"272\"></span></p>",
      "unique_key": "Q6801604",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Excessive use can result in methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patch in the image is an EMLA patch, which stands for Eutectic Mixture of Local Anesthetics. It is commonly used to numb the skin before procedures like needle insertions. The EMLA patch contains a mixture of two local anesthetics: lignocaine (also known as lidocaine) and prilocaine, each at a concentration of 2.5%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">One of the known side effects of prilocaine, especially when used in excessive amounts, is the risk of methemoglobinemia. This condition occurs when hemoglobin is converted to methemoglobin, which cannot effectively release oxygen to body tissues. Although the risk is generally low, it can be significant in infants and other at-risk populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. It is an Equal Mixture of Local Anesthetics:</strong> This statement is misleading. While the mixture contains equal concentrations of lignocaine and prilocaine (2.5% each), the term \"eutectic\" is key, indicating that the two anesthetics lower each other's melting points when combined, creating a mixture that is liquid at room temperature. The emphasis should be on the \"eutectic\" nature rather than just being an \"equal mixture.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It contains lignocaine and ropivacaine in a ratio of 50 percent each:</strong> This is incorrect because the EMLA patch contains lignocaine and prilocaine, not ropivacaine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 5 ml of 5 percent mixture contains 50 mg lignocaine:</strong> This calculation is incorrect. A 5% solution means 5 g of the drug is present in 100 ml of solution, which translates to 50 mg/ml. Therefore, 5 ml of the mixture would contain 250 mg of lignocaine, not 50 mg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prilocaine, one of the components of the EMLA patch, can cause methemoglobinemia, especially when used in excessive amounts or in vulnerable populations like infants.</span></p>",
      "correct_choice_id": 228559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80111,
      "choices": [
        {
          "id": 319160,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcal pneumonia</span></p>"
        },
        {
          "id": 319161,
          "text": "<p><span style=\"font-size:12.0pt;\">Kerosene oil aspiration</span></p>"
        },
        {
          "id": 319162,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung cancer</span></p>"
        },
        {
          "id": 319163,
          "text": "<p><span style=\"font-size:12.0pt;\">Mendelson syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Round pneumonia is most commonly associated with which of the following? (NEET PG 2016)</span></p>",
      "unique_key": "Q2683147",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021352,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Streptococcal pneumonia&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Round pneumonia is a distinct radiological pattern of pneumonia that appears as a round or oval opacity on chest imaging, mimicking a mass lesion. It is most commonly associated with Streptococcal pneumonia (Streptococcus pneumoniae infection). This presentation is particularly common in children under 8 years of age due to the lack of development of complete interlobular septae and pores of Kohn, which allows infection to spread more uniformly in a centrifugal pattern rather than respecting anatomical boundaries. Round pneumonia typically resolves completely with appropriate antibiotic therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Kerosene oil aspiration</strong> - Incorrect. Kerosene aspiration typically causes chemical pneumonitis with bilateral infiltrates, often with a predominantly basal distribution. It does not present as round pneumonia but rather as diffuse or patchy infiltrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lung cancer</strong> - Incorrect. While lung cancer can present as a round mass on imaging, this is not classified as round pneumonia. Round pneumonia is an infectious process that resolves with antibiotics, unlike malignant lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mendelson syndrome</strong> - Incorrect. This refers to chemical pneumonitis caused by aspiration of acidic gastric contents. It typically presents with bilateral infiltrates in dependent lung zones, not as a solitary round opacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Round pneumonia is a distinct radiological presentation most commonly caused by Streptococcus pneumoniae infection in children, appearing as a well-defined round opacity that may mimic a tumor but resolves completely with appropriate antibiotic therapy.</span></p>",
      "correct_choice_id": 319160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80098,
      "choices": [
        {
          "id": 319108,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory distress syndrome</span></p>"
        },
        {
          "id": 319109,
          "text": "<p><span style=\"font-size:12.0pt;\">Tracheoesophageal fistula</span></p>"
        },
        {
          "id": 319110,
          "text": "<p><span style=\"font-size:12.0pt;\">Meconium aspiration syndrome</span></p>"
        },
        {
          "id": 319111,
          "text": "<p><span style=\"font-size:12.0pt;\">Transient tachypnea of the newborn</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which neonatal condition is the gastric aspirate shake test used to evaluate? (NEET PG 2015)</span></p>",
      "unique_key": "Q8775906",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021486,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: A. Respiratory distress syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gastric aspirate shake test is a simple bedside test used to assess pulmonary surfactant in newborns. It evaluates the presence of surfactant in gastric aspirate, which correlates with surfactant levels in the lungs. This test is specifically used to evaluate for Respiratory Distress Syndrome (RDS), also known as Hyaline Membrane Disease, which is caused by surfactant deficiency in premature infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this test, gastric fluid is aspirated from the newborn and mixed with ethanol and saline. The mixture is then shaken and observed for stable foam formation. The presence of stable foam indicates adequate surfactant (negative test), while absence of foam indicates surfactant deficiency (positive test), suggesting RDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The test is particularly valuable in resource-limited settings where more sophisticated tests like amniotic fluid lecithin/sphingomyelin ratio or lamellar body counts may not be available.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tracheoesophageal fistula</strong> - Incorrect. Diagnosis of TEF usually involves passing a radiopaque nasogastric tube and obtaining radiographs to demonstrate coiling of the tube in the proximal esophageal pouch. The shake test has no role in diagnosing TEF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meconium aspiration syndrome</strong> - Incorrect. MAS is diagnosed based on history of meconium-stained amniotic fluid, clinical signs of respiratory distress, and characteristic radiographic findings. The shake test is not used in MAS evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Transient tachypnea of the newborn</strong> - Incorrect. TTN is diagnosed based on clinical presentation and radiographic findings showing fluid in the interlobar fissures and perihilar streaking. The shake test doesn't help in TTN diagnosis as surfactant levels are normal in TTN.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gastric aspirate shake test is a simple bedside test to evaluate surfactant deficiency in neonates, helping to diagnose Respiratory Distress Syndrome, particularly in settings where sophisticated laboratory tests are unavailable.</span></p>",
      "correct_choice_id": 319108,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6514,
      "choices": [
        {
          "id": 26025,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium chloride</span></p>"
        },
        {
          "id": 26026,
          "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 26027,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 26028,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamterene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels? (NEET PG 2021)</span></p>",
      "unique_key": "Q1153669",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021050,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Clarithromycin.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Clarithromycin is known to inhibit the cytochrome P450 system, which is involved in the metabolism of many drugs, including digoxin. By inhibiting the metabolism of digoxin, clarithromycin can lead to elevated levels of digoxin in the blood, increasing the risk for digoxin toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Clarithromycin also acts as an inhibitor of the P-glycoprotein and can precipitate Digoxin toxicity. P glycoproteins are drug efflux pumps in the intestine that lead to a decrease in the bioavailability of drugs. Digoxin is one of the drugs that utilizes this mechanism for its metabolism. Therefore, the drugs which inhibit the Pgp can lead to the increased plasma concentration of Digoxin and lead to its toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Other drugs that inhibit the Pgp include&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Amiodarone</span></li><li><span style=\"font-size:12.0pt;\">Verapamil</span></li><li><span style=\"font-size:12.0pt;\">Diltiazem</span></li><li><span style=\"font-size:12.0pt;\">Itraconazole</span></li><li><span style=\"font-size:12.0pt;\">Propafenone</span></li><li><span style=\"font-size:12.0pt;\">Flecainide&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Quinidine.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Potassium chloride:</strong> This medication primarily affects potassium levels and has no significant interaction with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol, a beta-blocker, is not known to significantly interact with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triamterene</strong>: This diuretic medication primarily affects sodium and potassium levels and is not known to have a significant impact on digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clarithromycin can significantly increase plasma levels of digoxin by inhibiting its metabolism through the cytochrome P450 system and by inhibiting P-glycoprotein, leading to an increased risk of digoxin toxicity.</span></p>",
      "correct_choice_id": 26026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76188,
      "choices": [
        {
          "id": 303625,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">10 January and 10 February</span></p>"
        },
        {
          "id": 303626,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">10 February and 10 August</span></p>"
        },
        {
          "id": 303627,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">1 February and 1 August</span></p>"
        },
        {
          "id": 303628,
          "text": "<p><span style=\"font-size:16px;\">1 March and 1 April</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">National Deworming Day is observed on:(FMGE JAN 2025)</span></p>",
      "unique_key": "Q2196667",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021142,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) 10 February and 10 August</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">National Deworming Day is observed on <strong>10th February</strong>, with a repeat round conducted after <strong>six months on 10th August.</strong> During this program, <strong>albendazole is used for deworming</strong>. In many states, the <strong>10th date of every month is observed as national deworming day</strong>, but the main nationwide observance is on these two dates.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">National Deworming Day is observed on <strong>10th February</strong> with a repeat round <strong>after 6 months on 10th August</strong>, using <strong>albendazole for deworming</strong>.&nbsp;</span></p>",
      "correct_choice_id": 303626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6516,
      "choices": [
        {
          "id": 26033,
          "text": "<p><span style=\"font-size:12.0pt;\">Grapefruit juice</span></p>"
        },
        {
          "id": 26034,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol</span></p>"
        },
        {
          "id": 26035,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepine</span></p>"
        },
        {
          "id": 26036,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI (Selective Serotonin Reuptake Inhibitor)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient has been diagnosed with bacterial vaginosis and trichomoniasis. She is prescribed metronidazole as part of her treatment plan. Which of the following should she avoid consuming while on this medication? (NEET PG 2021)</span></p>",
      "unique_key": "Q6166857",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021138,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alcohol</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Patients taking metronidazole are advised to avoid alcohol consumption. Metronidazole and alcohol can interact to cause a disulfiram-like reaction, leading to symptoms such as flushing, nausea, vomiting, palpitations, and even more severe reactions in some cases. This interaction can occur not only with oral alcohol consumption but also with alcohol contained in mouthwashes and certain medications.</span></li><li><span style=\"font-size:12.0pt;\">Disulfiram is an aversive drug, that inhibits the aldehyde dehydrogenase, leading to accumulation of acetaldehyde in the body, which can lead to symptoms like throbbing headache, flushing, chest tightness, visual disturbances, nausea etc. Hence these symptoms prevent the patient from taking alcohol.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Grapefruit juice</strong>: There is no known significant interaction between grapefruit juice and metronidazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Benzodiazepine</strong>: While caution may be advised when combining any medications that can have CNS effects, there is not a well-known, specific interaction between benzodiazepines and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SSRI</strong>: Similar to benzodiazepines, there is not a well-known, specific interaction between SSRIs and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drugs that can cause disulfiram like reaction include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C</strong>yclic:&nbsp; <strong>C</strong>efoperazone, <strong>C</strong>hlorpropamide</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>G: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; G</strong>rieseofulvin</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>M: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M</strong>etronidazole</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>P: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P</strong>rocarbazine</span></p>",
      "correct_choice_id": 26034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55539,
      "choices": [
        {
          "id": 221609,
          "text": "<p><span style=\"font-size:12.0pt;\">Cranial nerve 7</span></p>"
        },
        {
          "id": 221610,
          "text": "<p><span style=\"font-size:12.0pt;\">Cranial nerve 8</span></p>"
        },
        {
          "id": 221611,
          "text": "<p><span style=\"font-size:12.0pt;\">Cranial nerve 6</span></p>"
        },
        {
          "id": 221612,
          "text": "<p><span style=\"font-size:12.0pt;\">Cranial nerve 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a surgical procedure in the ear, the surgeon injured a nerve which led to lagophthalmos after the surgery. Which nerve was likely to be damaged? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2771130",
      "question_audio": null,
      "question_video": null,
      "map_id": 24021484,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Cranial nerve 7</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lagophthalmos is the inability to fully close the eyelids, typically due to paralysis of the orbicularis oculi muscle. This muscle is innervated by the facial nerve, also known as Cranial Nerve 7. During ear surgery, the facial nerve can be vulnerable to injury, especially in procedures involving the middle ear or mastoid region. Damage to this nerve results in a loss of motor control to the muscles of facial expression, including those responsible for eyelid closure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cranial nerve 8:&nbsp;</strong>It is vestibulo cochlear nerve which is having the function of hearing &amp; equilibrium</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cranial nerve 6:</strong> The sixth cranial nerve, or abducens nerve, controls the lateral rectus muscle of the eye, which is responsible for eye abduction. Injury to this nerve causes problems with lateral eye movement, not with eyelid closure, making it an incorrect choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cranial nerve 5:</strong> The fifth cranial nerve, or trigeminal nerve, is primarily responsible for sensation in the face and motor functions such as biting and chewing. While it has a minor role in reflexive blinking (via the corneal reflex), it does not control the orbicularis oculi muscle, so its injury would not cause lagophthalmos.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The facial nerve (Cranial Nerve 7) controls the muscles of facial expression, including the orbicularis oculi muscle, and injury to this nerve can result in lagophthalmos.</span></p>",
      "correct_choice_id": 221609,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}